Artificial Intelligence in Drug Discovery
Un podcast de Simon Smith
12 Épisodes
-
Nick Lynch of the Pistoia Alliance on AI as a Strategic Focus
Publié: 07/08/2018 -
Lucas Siow of ProteinQure on AI for Protein-Based Drugs
Publié: 07/08/2018 -
Regina Barzilay, AI Small Molecule Discovery and Synthesis
Publié: 30/07/2018 -
Tim Guilliams and David Brown, Healx, AI for Rare Diseases
Publié: 26/07/2018 -
John Cassidy, CEO, Cambridge Cancer Genomics, AI in Oncology
Publié: 18/07/2018 -
Kristen Fortney, CEO of BioAge Labs, on AI Aging Research
Publié: 10/07/2018 -
Sam Cooper, CEO of Phenomic AI, on Automated HCS and More
Publié: 28/06/2018 -
Shai Shen-Orr, Chief Scientist, CytoReason, AI in Immunology
Publié: 20/06/2018 -
Leila Pirhaji, CEO of ReviveMed, on AI for Metabolomics
Publié: 11/06/2018 -
Mostapha Benhenda of Startcrowd on AI Drug Discovery Hype
Publié: 29/05/2018 -
Mauro Cozzi, Researchably, AI for Better Biomedical Search
Publié: 22/05/2018 -
Dekel Gelbman, CEO of FDNA, on "Next-Generation Phenotyping"
Publié: 14/05/2018
1 / 1
Get knowledge and inspiration to apply artificial intelligence to drug development. Discover startups applying machine learning to biomedical research. Hear how biotech and pharma companies use AI to speed discovery and cut costs. Learn from academic researchers pushing boundaries in applying computation to biology. We interview leaders transforming drug development with data and algorithms. Subscribe now and never miss an episode!
